The Abbott Laboratories story
What drives Abbott Laboratories, what its price assumes and what could change the story, written from its own filings.
- Diagnostics has changed. Exact Sciences helped lift reported Diagnostics growth to 46.7 percent in the quarter to September 2026, versus 6.4 percent on a comparable basis.
- Nutrition heads toward independence. Abbott intends to separate its approximately $8.5 billion annual Nutrition business through a tax-free distribution to shareholders by the end of 2027.
- Growth carries costs. In the quarter to September 2026, adjusted diluted earnings per share rose 9.2 percent, but reported earnings absorbed substantial amortization and legal settlement charges.
